Publicacións (23) Publicacións nas que participase algún/ha investigador/a

2018

  1. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

    Blood Advances, Vol. 2, Núm. 14, pp. 1719-1737

  2. Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals

    Hematology/ Oncology and Stem Cell Therapy, Vol. 11, Núm. 2, pp. 118-121

  3. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

    Hematological Oncology, Vol. 36, Núm. 5, pp. 765-772

  4. Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes

    European Journal of Haematology, Vol. 101, Núm. 3, pp. 332-339

  5. Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

    British Journal of Haematology

  6. Coagulación intravascular diseminada en el paciente quemado

    Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 16, pp. 16-21

  7. Enfermedad de von Willebrand

    Hemostasia y trombosis: manual práctico (Arán), pp. 67-76

  8. Essential thrombocythaemia with mutation in MPL: Clinicopathological correlation and comparison with JAK 2V617F-mutated and CALR- mutated genotypes

    Journal of Clinical Pathology, Vol. 71, Núm. 11, pp. 975-980

  9. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

    Blood Cancer Journal, Vol. 8, Núm. 10

  10. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012

    American Journal of Hematology, Vol. 93, Núm. 5, pp. 643-648

  11. Hypergranular lymphoblastic leukaemia

    British Journal of Haematology

  12. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

    Haematologica, Vol. 103, Núm. 1, pp. 148-162

  13. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

    Leukemia, Vol. 32, Núm. 1, pp. 21-29

  14. Microangiopatías trombóticas

    Hemostasia y trombosis: manual práctico (Arán), pp. 121-131

  15. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

    Annals of Hematology, Vol. 97, Núm. 11, pp. 2217-2224

  16. Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis

    Leukemia

  17. Prognostic risk models for transplant decision-making in myelofibrosis

    Annals of Hematology, Vol. 97, Núm. 5, pp. 813-820

  18. Red blood cell transfusion after a global strategy for early detection and treatment of iron deficiency anemia: three-year results of a prospective observational study

    Transfusion, Vol. 58, Núm. 6, pp. 1399-1407

  19. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

  20. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060